NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I believe they will be able to do serial processing in these units. The whole point of them is that they are doing the work inside of a sealed cartridge, hence the elimination of cleanrooms. When the product is idle, and the cells are digesting, discovering and processing antigens, there is no reason why the next cartridge cannot be in process, in the long-run. I think per unit they will ultimately do far more than 50 a year. It’s clearly what the technology was ultimately invented to achieve.

I think ultimately, the company will need to consider scaling that process beyond individual units as well, to automate beyond and to where the cost can be scaled waaaay down.